Cellect Biotech stock rises 71% after announcing successful stem cell transplant procedure – MarketWatch
InvestopediaCellect Biotech stock rises 71% after announcing successful stem cell transplant procedureMarketWatchCellect Biotechnology Ltd. ADR APOP, +83.26% shares rose 71.3% in heavy volume after the company said on Monday that it had completed the f… Continue reading
